Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1954 4
1956 1
1962 1
1963 1
1964 1
1966 4
1967 2
1968 5
1969 2
1970 6
1971 3
1972 3
1973 2
1974 4
1975 2
1976 3
1977 1
1978 5
1979 2
1980 11
1981 9
1982 9
1983 9
1984 10
1985 9
1986 22
1987 12
1988 23
1989 17
1990 13
1991 16
1992 21
1993 14
1994 25
1995 18
1996 24
1997 16
1998 22
1999 21
2000 22
2001 15
2002 20
2003 17
2004 14
2005 14
2006 25
2007 19
2008 8
2009 19
2010 30
2011 19
2012 34
2013 23
2014 25
2015 22
2016 34
2017 30
2018 27
2019 20
2020 39
2021 56
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

847 results
Results by year
Filters applied: . Clear all
Page 1
Janus kinases to jakinibs: from basic insights to clinical practice.
Gadina M, Le MT, Schwartz DM, Silvennoinen O, Nakayamada S, Yamaoka K, O'Shea JJ. Gadina M, et al. Among authors: yamaoka k. Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i4-i16. doi: 10.1093/rheumatology/key432. Rheumatology (Oxford). 2019. PMID: 30806710 Free PMC article. Review.
Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.
Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, Ando T, Nakayama Y, Okuzono Y, Takiguchi M, Kurisu R, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T. Tasaki S, et al. Among authors: yamaoka k. Nat Commun. 2018 Jul 16;9(1):2755. doi: 10.1038/s41467-018-05044-4. Nat Commun. 2018. PMID: 30013029 Free PMC article.
Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study.
Kameda H, Takeuchi T, Yamaoka K, Oribe M, Kawano M, Zhou Y, Othman AA, Pangan AL, Kitamura S, Meerwein S, Tanaka Y. Kameda H, et al. Among authors: yamaoka k. Rheumatology (Oxford). 2020 Nov 1;59(11):3303-3313. doi: 10.1093/rheumatology/keaa084. Rheumatology (Oxford). 2020. PMID: 32277824 Free PMC article. Clinical Trial.
[JAK inhibitor].
Yamaoka K, Tanaka Y. Yamaoka K, et al. Nihon Rinsho. 2013 Jul;71(7):1243-7. Nihon Rinsho. 2013. PMID: 23961674 Review. Japanese.
Reply from the authors.
Kawaoka T, Ando Y, Yamauchi M, Suehiro Y, Yamaoka K, Kosaka Y, Fuji Y, Uchikawa S, Morio K, Fujino H, Nakahara T, Ono A, Murakami E, Takahashi S, Tsuge M, Hiramatsu A, Imamura M, Chayama K, Aikata H. Kawaoka T, et al. Among authors: yamaoka k. Hepatol Res. 2020 Dec;50(12):1393. doi: 10.1111/hepr.13578. Hepatol Res. 2020. PMID: 33280200 No abstract available.
The Janus kinases (Jaks).
Yamaoka K, Saharinen P, Pesu M, Holt VE 3rd, Silvennoinen O, O'Shea JJ. Yamaoka K, et al. Genome Biol. 2004;5(12):253. doi: 10.1186/gb-2004-5-12-253. Epub 2004 Nov 30. Genome Biol. 2004. PMID: 15575979 Free PMC article. Review.
Janus kinase inhibitors for rheumatoid arthritis.
Yamaoka K. Yamaoka K. Curr Opin Chem Biol. 2016 Jun;32:29-33. doi: 10.1016/j.cbpa.2016.03.006. Epub 2016 Mar 17. Curr Opin Chem Biol. 2016. PMID: 26994322 Review.
847 results